SMARCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Likewise, in the haploid CML cell line HAP1, depletion of SMARCB1 or ARID1A increased resistance to doxorubicin, and depletion of SMARCB1 also increased resistance to paclitaxel and vinblastine [233].